Commonly Used Therapeutic Drugs in Rodents

Similar documents
Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.

STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA

STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA

Procedure # IBT IACUC Approval: December 11, 2017

LABORATORY ANIMAL BIOMETHODOLOGY WORKSHOP MODULE 3 Rodent Analgesia and Anesthesia

Anesthetic regimens for mice, rats and guinea pigs

SOP #: Page: 1 of 6 Rodent Analgesia

Washington State University Institutional Animal Care and Use Committee

Is Atipamezole better than Yohimbine for reversal of Xylazine in male C57BL/6 mice anesthetized with Ketamine/Xylazine?

PROTOCOL FOR ANIMAL USE AND CARE

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

INTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre

DOSE ROUTE FREQUENCYREFERENCENOTES

GUIDELINES FOR ASEPTIC RECOVERY SURGERY ON RODENTS AND BIRDS. Adopted by the University Committee on Animal Resources May 18, 2011

The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary

2012 National FFA Veterinary Science CDE Math Practicum KEY

UNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee

Antibiotic Treatment of Peritonitis

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

St George/Sutherland Hospitals And Health Services (SGSHHS)

UNTHSC. Institutional Animal Care and Use Committee. Title: Analgesics and Anesthesia in Laboratory Animals at UNTHSC. Document #: 035 Version #: 02

EXCEDE Sterile Suspension

Gentamicin or Tobramycin for Peritonitis in Peritoneal Dialysis

POST-OPERATIVE ANALGESIA AND FORMULARIES

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Commonly Used Analgesics

Infecting Anopheles stephensi With Rodent Malaria Parasites Alida Coppi & Photini Sinnis

GUIDELINES FOR ANESTHESIA AND FORMULARIES

WITHDRAWAL TIME RECOMMENDATIONS ARIZONA RACE TRACKS MEET

ANNEX III LABELLING AND PACKAGE LEAFLET

Performing Rodent Survival Surgery

Pain Management. Anesthesia Asepsis Analgesia Euthanasia

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods

EC-AH-011v1 January 2018 Page 1 of 5. Standard Operating Procedure Equine Center Clemson University

Rodent Surgery (AU_RS) Course Material

SUMMARY OF PRODUCT CHARACTERISTICS

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton

Meloxicam withdrawal time veterinarian bovine

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Animal Studies Committee Policy Rodent Survival Surgery

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

Mass Delivery of Nonsurgical Sterilants

Sites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site:

STANDARD OPERATING PROCEDURE SOP# 619 COMMON RODENT TREATMENTS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

STANDARD OPERATING PROCEDURE RODENT SURVIVAL SURGERY

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

B. PACKAGE LEAFLET 1

MEDICATION ADMINSITRATION: ANTIBIOTIC LOCK THERAPY GUIDELINE

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

DREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS

LARC FORMULARY ANESTHESIA AND ANALGESIA IN LABORATORY ANIMALS

SURGICAL (SURVIVAL) OOCYTE COLLECTION FROM XENOUS LAEVIS

FWC Division of Law Enforcement

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

The Guide for the Care and Use of Laboratory Animals, 8th Edition, November Euthanasia. pp

SUMMARY OF PRODUCT CHARACTERISTICS. Enrotron 50 mg/ml Solution for injection for cattle, pigs, dogs and cats


NUMBER: R&C-ARF-10.0

CLINICAL ESSENTIAL HUDDLE CARD. All associates must comply with their state practice acts.

CAUTION Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.

SUMMARY OF PRODUCT CHARACTERISTICS

Treatment Protocol. Diagnosis Clinical Signs Treatment Protocol and Dose Withdrawal. Period (slaughter)

Summary of Product Characteristics

ZOETIS INC. 333 PORTAGE STREET, KALAMAZOO, MI, Telephone: Customer Service: Website: EXCEDE FOR SWINE

SUMMARY OF PRODUCT CHARACTERISTICS

NUMBER: /2005

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

Administering Medication and Care

N.C. A and T List of Approved Analgesics 1 of 5

Washington State University Institutional Animal Care and Use Committee Management of Ulcerative Dermatitis in Mice Approved: 06/27/2018

Dexmedetomidine and its Injectable Anesthetic-Pain Management Combinations

DOSAGE FORMS AND STRENGTHS Otic Suspension: Each OTIPRIO vial contains 1 ml of 6% (60 mg/ml) ciprofloxacin otic suspension. (3)

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

SUMMARY OF PRODUCT CHARACTERISTICS

Example 1: Quality Assurance Individual

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

Iowa State University Institutional Animal Care and Use Committee. Institutional Animal Care and Use Committee (IACUC) Standard Operating Procedure

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Guidance Document. Veterinary Operating Instructions. Guidance re: Requirements for Authorising Veterinarians Notice.

Inflammatory pain in cattle

Fasciolosis Clinical Symptoms Diagnosis Treatment and Prevention Management

Iowa State University Institutional Animal Care and Use Committee. Institutional Animal Care and Use Committee (IACUC) Standard Operating Procedure

Veterinary Dispensing Technician Educational Packet

COPPER RING TYPE TERMINAL

Scientific Discussion post-authorisation update for Rheumocam extension X/007

Compounded Ophthalmic Formulations

Metacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.

SUMMARY OF PRODUCT CHARACTERISTICS

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

FREEDOM OF INFORMATION (FOI) SUMMARY

Health Products Regulatory Authority

INVITATION TO BID BL038-18

Alabama D E E R A S S O C I AT I O N

RABIES AND ITS PREVENTION. IAP UG Teaching Slides

Transcription:

Commonly Used Therapeutic Drugs in Rodents Common Medical Conditions Dermatitis, bite wounds Eye infections Systemic infections Treatment Clip hair and clean with 0.2% chlorhexidine solution or betadine solution Triple antibiotic ointment, ophthalmic preparation if lesion near eyes Silvadene cream Collasate Spray or Ointment Zn7 Derm Spray or Ointment Carprofen (5-20 mg/kg SQ), Meloxicam ( 5-10 mg/kg SQ) Triple antibiotic ophthalmic ointment Enrofloxacin (10 mg/kg SQ) Note 1: After notification of a rodent health concern as described above, the facility manager or designee should initiate treatment according to the table. The health concern should be noted on the Animal Health Concern Form (CMDC 155) for follow-up by a veterinarian. Note 2: Initiation of the treatment should be annotated on the Progress Notes Form (CMDC 013) in the room log book according to SOP 006: Animal Health and Environmental Surveillance. Note 3: All treatments are BID for 7 days. Note 4: Systemic antibiotics should only be administered after consultation with a Veterinarian unless described in the IACUC protocol Page 1 of 7

Page 2 of 7 Baytril (enrofloxacin) Dilution Preparation for Rats 1. Always decontaminate the Baytril vial, NaCl bag port, and NaCl vials with ethanol before inserting a sterile needle, withdrawing compound, or injecting drug. a. If using Baytril (enrofloxacin) 2.27% (22.7mg/ml) stock solution 1) To make a 10ml Vial i. Use a prepackaged sterile 10ml 0.9%NaCl preservative free vial ii. Remove 2.2mls NaCl iii. Add 2.2 mls Baytril (22.7mg/ml) stock solution iv. Final concentration of new dilution is 5mg/ml b. If using Baytril (enrofloxacin) 100mg/ml stock solution 1) To make a 10ml vial i. Use a prepackaged sterile 10ml 0.9%NaCl preservative free vial ii. Remove 0.5 mls NaCl iii. Add 0.5 mls Baytril stock solution (100mg/ml) iv. Final concentration of new dilution is 5 mg/ml 2) To make a 100ml Bag i. Use a sterile 100ml bag of 0.9% NaCl ii. Remove 5mls of NaCl iii. Add 5mls Baytril (100mg/ml) stock solution iv. Final concentration of new dilution is 5mg/ml 3. Label the vial as follows: a. Name of the drug (Baytril/NaCl solution) b. Strength of the drug (5mg Baytril/ml) c. Day of constitution d. Initials of constituting technician e. Dose of the drug for rats (10 mg/kg BW, SQ) f. Baytril injection volumes for rats (based on grams of body weight (BW) 1) 250 gm BW = 0.50 ml 2) 275 gm BW = 0.55 ml 3) 300 gm BW = 0.60 ml 4) 325 gm BW = 0.65 ml 5) 350 gm BW = 0.70 ml 6) 375 gm BW = 0.75 ml 7) 400 gm BW = 0.80 ml 8) 425 gm BW = 0.85 ml 9) 450 gm BW = 0.90 ml 10) 475 gm BW = 0.95 ml 11) 500 gm BW = 1.00 ml g. Decontaminate vial port with ethanol prior to each withdrawal. h. Discard vial and contents on (date 28 days after constitution), or if solution

Baytril (enrofloxacin) Dilution Preparation for Mice 1. Always decontaminate the Baytril vial, NaCl bag port, and NaCl vials with ethanol before inserting a sterile needle, withdrawing compound, or injecting drug. a. If using Baytril (enrofloxacin) 2.27% (22.7mg/ml) stock solution 1) To make a 10ml Vial i. Use prepackaged 10ml sterile 0.9% NaCl preservative free vial ii. Remove 0.45 ml NaCl from Vial iii. Add 0.45 ml Baytril (22.7mg/ml) stock solution iv. Final concentration of new dilution is 1.0 mg/ml b. If using Baytril (enrofloxacin) 100mg/ml stock solution 1) To make a 10ml vial i. Use prepackages 10ml sterile 0.9% NaCl preservative free vial ii. Remove 0.1ml NaCl from vial iii. Add 0.1ml Baytril (100mg/ml) stock solution iv. Final Concentration of new dilution is 1.0 mg/ml 2) To make a 100ml Bag i. Use a sterile 100ml bag of 0.9% NaCl ii. Remove 1ml NaCl from bag of 0.9% NaCl iii. Add 1.0ml Baytril (100mg/ml) stock solution iv. Final Concentration of new dilution is 1.0 mg/ml 3. Label the vial as follows: a. Name of the drug (Baytril/saline solution) b. Strength of the drug (1mg Baytril/ml) c. Day of constitution d. Initials of constituting technician e. Dose of the drug for mice (10.0 mg/kg BW, SQ) f. Baytril injection volumes for mice (based on grams of body weight BW): 1) 15 gm BW = 0.15 ml 2) 20 gm BW = 0.20ml 3) 25 gm BW = 0.25 ml 4) 30 gm BW = 0.30 ml 5) 35 gm BW = 0.35 ml 6) 40 gm BW = 0.40 ml 7) 45 gm BW = 0.45 ml a. Decontaminate vial port with ethanol prior to each withdrawal. b. Discard vial and contents on ( date 28 days after constitution), or if solution Page 3 of 7

Carprofen Dilution Preparation for Rats 1. Always decontaminate the Carprofen vial stopper, sterile 0.9% NaCl vials, and 0.9% NaCl Bags with ethanol before inserting a sterile needle. a. Using a 100ml bag of sterile NaCl 1) Remove 5.0 mls NaCl from 100ml bag 2) Add 5.0 ml Carprofen (50mg/ml stock solution) b. Using a 10ml vial of NaCl 1) Remove 0.5 ml NaCl from 10ml vial 2) Add 0.5 ml Carprofen (50mg/ml stock solution) 3. Label the bag / vial as follows: a. name of the drug (Carprofen/saline solution) b. strength of the drug (2.5 mg Carprofen/ml) c. date of constitution d. initials of constituting technician e. dose of the drug for rats (5 mg/kg BW, SQ) f. Carprofen injection volumes for rats (body weight [BW]) SC: 1) 250 gm BW = 0.50 ml 2) 275 gm BW = 0.55 ml 3) 300 gm BW = 0.60 ml 4) 325 gm BW = 0.65 ml 5) 350 gm BW = 0.70 ml 6) 375 gm BW = 0.75 ml 7) 400 gm BW = 0.80 ml 8) 425 gm BW = 0.85 ml 9) 450 gm BW = 0.90 ml 10) 475 gm BW = 0.95 ml 11) 500 gm BW = 1.00 ml g. Decontaminate bag port with ethanol prior to each withdrawal. h. "Keep refrigerated." i. Discard bag and contents on (date 28 days after constitution), or if solution Page 4 of 7

Carprofen Dilution Preparation for Mice 1. Always decontaminate the Carprofen vial stopper, sterile 0.9% NaCl vials, and 0.9% NaCl Bags with ethanol before inserting a sterile needle. a. Using a 100ml bag of sterile NaCl 1) Remove 2.0 mls NaCl from 100ml bag 2) Add 2.0 ml Carprofen (50mg/ml stock solution) b. Using a 10ml vial of NaCl 1) Remove 0.2ml NaCl from 10ml vial 2) Add 0.2ml Carprofen (50mg/ml stock solution) 3. Label the bag / vial as follows: a. name of the drug (Carprofen/saline solution) b. strength of the drug (1.0 mg Carprofen/ml) c. date of constitution d. initials of constituting technician e. dose of the drug for mice (8-11 mg/kg BW, SQ) f. Carprofen injection volumes for mice (body weight [BW]) SC: 1) 15 g BW = 0.15 ml 2) 20 g BW = 0.20 ml 3) 25 g BW = 0.25 ml 4) 30 g BW = 0.30 ml 5) 35 g BW = 0.35 ml g. Decontaminate bag port with ethanol prior to each withdrawal. h. "Keep refrigerated." i. Discard bag and contents on (date 28 days after constitution), or if solution Page 5 of 7

Ketoprofen Dilution Preparation for Mice 1. Always decontaminate the ketoprofen vial stopper with ethanol before inserting a sterile needle. 2. Always decontaminate the saline bag port with ethanol before injecting the drug. 3. To prepare the mixture, inject 1.2 ml ketoprofen (of the 100mg/ml strength) in a 150 ml bag of sterile saline. 4. Label the bag as follows: a. name of the drug (ketoprofen/saline solution) b. strength of the drug (0.8 mg ketoprofen/ml) c. day of constitution d. initials of constituting technician e. dose of the drug for mice (8-11 mg/kg BW, SQ) f. ketoprofen injection volumes for mice (based on grams of body weight (BW): 1) 15 g BW = 0.2 ml 2) 20 g BW = 0.25 ml 3) 25 g BW = 0.3 ml 4) 30 g BW = 0.35 ml 5) 35 g BW = 0.4 ml g. Decontaminate bag port with ethanol prior to each withdrawal. h. Discard bag and contents on (date 28 days after constitution), or if solution 5. Label the vial as follows: a. strength of the drug (0.8 mg ketoprofen/ml) b. dose of the drug for mice (10 mg/kg BW, SQ) c. Expiration date: (28days after constitution) Page 6 of 7

Ketamine/Xylazine Dilution Preparation for Mice 1. Always decontaminate the Ketamine vial, Xylazine vial, and NaCl vials with ethanol before inserting a sterile needle, withdrawing or injecting drug. a. To make a 10ml vial 1) Use prepackaged 10ml sterile 0.9% NaCl preservative free vial 2) Remove 1.1ml NaCl from vial 3) Add 1.0ml Ketamine (100mg/ml) stock solution 4) Add 0.1ml Xylazine (100mg/ml) stock solution 5) Final concentration of new dilution is Ketamine 10mg/ml with Xylazine 1mg/ml 3. Labeling a. Label the vial as follows: 1) Name of the drug (Ketamine/Xylazine Injectable) 2) Strength of the drug (Ketamine 1.0mg/ml with Xylazine 0.1mg/ml) 3) Date prepared 4) Dose of the drug for mice (0.1 mg/kg BW, SQ) 5) Expires 24 hours after prepared 4. Ketamine/Xylazine injection volumes for mice (based on grams of body weight BW): a. Decontaminate vial port with ethanol prior to each withdrawal. 1) 15 gm BW = 0.15 ml 2) 20 gm BW = 0.20ml 3) 25 gm BW = 0.25 ml 4) 30 gm BW = 0.30 ml 5) 35 gm BW = 0.35 ml 6) 40 gm BW = 0.40 ml 7) 45 gm BW = 0.45 ml 5. Expiration date: 24 hours after prepared a. Discard vial and contents 24 hours after dispensing, or if solution changes in appearance, e.g. discoloration, precipitation, opacity. Page 7 of 7